MiniMed Group is trading at $18.86 (-6.91%) after its September 1, 2026 earnings report, as investors weigh margin pressure and earnings expectations despite strong sales.

  • Revenue reached $843 million, while U.S. pump sales grew 20%.
  • Management raised FY2027 organic revenue-growth guidance to approximately 10.5%, but maintained a roughly 16% adjusted EBITDA margin outlook.
  • The report was scheduled before market open.